Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Multiple Sclerosis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Multiple Sclerosis
    TopAbstracts in Multiple Sclerosis 02/04/2010 - (DGNews)
    TopAbstracts in Multiple Sclerosis 01/26/2010 - (DGNews)
    A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis - (N Engl J Med)
    Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis - (N Engl J Med)
    A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis - (N Engl J Med)

    News archive

     Recent webcasts/CME - Multiple Sclerosis
    • Selecting Immunomodulating Therapy in Relapsing-Remitting Multiple Sclerosis
    • Delaying the Conversion of Clinically Isolated Syndrome to Relapsing-Remitting Multiple Sclerosis Through Early Intervention With Disease-Modifying Therapy
    • Delaying Disease Progression in Patients With MS Who Become Nonresponsive to Established Disease-Modifying Therapies
    • Multiple Sclerosis: Tempering Disabilities and Decline--Fundamentals for Managed Markets
      Evidence-Based Update for NPs and PAs in the Diagnosis and Management of Multiple Sclerosis

      Webcasts/CME archive

       Recent cases - Multiple Sclerosis
        Patient With Neuromyelitis Optica And Inflammatory Demyelinating Lesions Comprising Whole Spinal Cord From C2 Level Till Conus: Case Report
        Encephalomyelitis Mimicking Multiple Sclerosis Associated with Chronic Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation
        Progressive Primary Form of Multiple Sclerosis: Clinical and Radiological Improvement with Methylprednisolone in Continuous Pulsetherapy in One Case for 16 Years
        Burrowing of Urinary Bladder Wall by the Tip of a Size 22 Fr Silicone Foley Catheter in an Adult Male Patient With Multiple Sclerosis and Suprapubic Cystostomy: Should Caution be Exercised in Using a Size 22 Fr Silicone Foley Catheter for Long-Term Drainage of Neuropathic Bladder?
        Central Auditory Evaluation in Multiple Sclerosis: Case Report

        Cases archive
          




        my personal edition > multiple sclerosis > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Abnormalities in Sex Hormones May Contribute to Brain Damage of Multiple Sclerosis

        LONDON, UK -- January 18, 2005 -- Abnormalities in sex hormone levels may contribute to the damage to brain tissue typical of multiple sclerosis, indicates research in the Journal of Neurology Neurosurgery and Psychiatry.

        Researchers analysed the sex hormone levels of 36 healthy people and compared them with those of 60 men and women with the relapsing-remitting form of multiple sclerosis (MS). The average age of the participants was 32, and those with MS had had their disease for an average of six years.

        The hormones tested included follicle stimulating hormone (FSH), luteinising hormone, oestradiol, testosterone, and dehydroepiandrosterone sulphate (DHEAs).

        In women, hormone levels were tested during both phases of their menstrual cycle, to account for variations. None of the women had used oral contraceptives, and all had normal cycles.

        The 25 men and 35 women with MS were also given brain scans (magnetic resonance imaging or MRI) to identify areas of tissue damage and inflammation, caused by the disease.

        Compared with healthy women, those with MS had lower levels of the male hormone testosterone in both phases of their menstrual cycle.

        And those with the lowest testosterone levels also had the highest amount of inflammation in their brain tissue, expressed as the number of gadolinium enhancing lesions.

        Women with MS and abnormally high testosterone levels also had greater levels of brain damage and a trend towards increased disability.

        Among men, there were no differences in testosterone levels between those with MS and the healthy group. But men with MS and the highest levels of the female hormone oestrogen also had the greatest degree of brain tissue damage.

        None of the other hormones seemed to have any impact on the findings.

        While the degree of overall brain damage was similar in the men and women, women tended to have more signs of inflammation than men. Previous research by the same team has indicated that there could be a gender difference in the progression of MS, with men tending to have more progressive and severe disease.


        Tomassini V, et al. Sex Hormones Modulate Brain Damage in Multiple Sclerosis: MRI Evidence. J Neurol Neurosurg Psychiatry 2005; 76:272-5.

        Click here to view the paper in full:
        http://press.psprings.co.uk/jnnp/february/272_jn33324.pdf


        SOURCE: British Medical Journal



        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2010 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send